Payload technology to optimize radioimmunotherapies - A novel treatment option for cancer patients resistant to chemotherapy - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

55291.1 IP-LS

Project title

Payload technology to improve radioimmunotherapies - A novel treatment option for cancer patients resistant to chemotherapy

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Inserted texts

Category	Text
Short description (German)	Payload technology to improve radioimmunotherapies - A novel treatment option for cancer patients resistant to chemotherapy
Short description (English)	Payload technology to optimize radioimmunotherapies - A novel treatment option for cancer patients resistant to chemotherapy
Abstract (German)	We develop a novel antibody-radionuclide conjugate (ARC), L1CAM-Tb-161, offering a new therapeutic window for patients with resistance to chemotherapy. Based on our non-toxic polymer-payload technology we conjugate common & novel isotopes to an antibody targeting the human cell adhesion molecule L1.